Physician

Mark R Bowers, MD

According to 2025 Medicare claims, Mark Bowers, MD (NPI: 1184788960) practices cardiac electrophysiology in the Redding, CA market, with the plurality of this provider's patient population coming from Shasta, CA. This provider's primary affiliated billing organization is DIGNITY HEALTH MEDICAL FOUNDATION (NPI: 1700803418; TIN: 770359115) and primary practice location at 95819-3626. Bowers is affiliated with the CommonSpirit ACO I (ACO ID: A2164), participating under the MSSP model.

Bowers' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,062 traditional Medicare patients, billed 4,649 HCPCS/CPT codes, and received $671,376 in Medicare payments. The top billing code was 93656 (Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation). Part D data shows 710 prescription claims across 191 beneficiaries totaling $186,030 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 84 records totaling $40,839. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $263,099 to $671,376. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $105,125 and ending at $186,030. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	560	2,065	$263,099
2016	718	3,093	$367,503
2017	810	3,881	$417,237
2018	878	4,077	$413,120
2019	874	4,354	$483,920
2020	811	4,255	$522,724
2021	811	4,225	$525,122
2022	976	4,596	$556,946
2023	1,082	4,693	$662,117
2024	1,062	4,649	$671,376

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	180	764	$105,125
2016	280	1,307	$146,613
2017	331	1,629	$276,061
2018	358	1,857	$322,849
2019	350	1,712	$255,390
2020	348	1,693	$340,472
2021	322	1,438	$353,660
2022	272	1,230	$342,333
2023	231	947	$270,447
2024	191	710	$186,030

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93656	Comprehensive electrophysiologic evaluation with catheter destruction of abnormality causing atrial fibrillation (uncoordinated contraction of upper chambers of heart) by pulmonary vein isolation	230	234	$755
93657	Destruction of tissue of upper heart chamber through tube to treat abnormal heart rhythm	228	453	$248
93609	Insertion of tube in upper and/or lower heart chambers to record and identify origin of abnormal heart rhythm	261	268	$221
93294	Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days	308	620	$22
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	219	239	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	136	6,360	$122,901
Xarelto	Rivaroxaban	54	1,620	$29,966
Entresto	Sacubitril/Valsartan	13	690	$15,063
Flecainide Acetate	Flecainide Acetate	87	4,500	$3,543
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	48	2,213	$1,281

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	84	$40,839	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark R. Bowers, MD?

Tedicare shows public-source Medicare data for Mark R. Bowers, MD (NPI 1184788960), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark R. Bowers, MD have ACO affiliation data?

Mark R. Bowers, MD is shown with ACO affiliation data for CommonSpirit ACO I (MSSP, ACO ID A2164).

What billing organization is linked to Mark R. Bowers, MD?

Mark R. Bowers, MD is linked to DIGNITY HEALTH MEDICAL FOUNDATION (billing NPI 1700803418) in the available physician profile data.

Does Mark R. Bowers, MD have Open Payments data?

Mark R. Bowers, MD has 84 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.